Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8319 |
Intermediate Similarity |
NPD1358 |
Approved |
0.824 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.814 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8083 |
Intermediate Similarity |
NPD3134 |
Approved |
0.8077 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8077 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8056 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7923 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7862 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7852 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7836 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7803 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7794 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7754 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7754 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7697 |
Intermediate Similarity |
NPD919 |
Approved |
0.7671 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7655 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7638 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7622 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7576 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD2653 |
Approved |
0.7566 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7566 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7559 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7557 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7554 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7554 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7536 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7534 |
Intermediate Similarity |
NPD5297 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7518 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1933 |
Approved |
0.75 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7465 |
Intermediate Similarity |
NPD3748 |
Approved |
0.745 |
Intermediate Similarity |
NPD3687 |
Approved |
0.745 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7445 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7432 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7424 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7419 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7419 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7415 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7381 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7376 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7364 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7344 |
Intermediate Similarity |
NPD228 |
Approved |
0.7329 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7319 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7303 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7293 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7292 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7292 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7287 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7279 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7266 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7255 |
Intermediate Similarity |
NPD37 |
Approved |
0.7254 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7252 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7246 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7241 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD17 |
Approved |
0.7239 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7218 |
Intermediate Similarity |
NPD7533 |
Approved |
0.7218 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7218 |
Intermediate Similarity |
NPD7534 |
Approved |
0.7214 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7211 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7208 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7206 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7192 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7181 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7179 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7163 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7162 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7161 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD4359 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7152 |
Intermediate Similarity |
NPD920 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7152 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1408 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7132 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7124 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7123 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD7054 |
Approved |
0.709 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6653 |
Approved |
0.708 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7078 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7078 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7078 |
Intermediate Similarity |
NPD5089 |
Approved |
0.707 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD7472 |
Approved |
0.705 |
Intermediate Similarity |
NPD3266 |
Approved |
0.705 |
Intermediate Similarity |
NPD3267 |
Approved |
0.705 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7042 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD411 |
Approved |
0.704 |
Intermediate Similarity |
NPD291 |
Approved |
0.7037 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7031 |
Intermediate Similarity |
NPD290 |
Approved |
0.703 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7027 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD4210 |
Discontinued |
0.6993 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6987 |
Remote Similarity |
NPD4585 |
Approved |
0.698 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6974 |
Remote Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD2492 |
Phase 1 |
0.6963 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6959 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6948 |
Remote Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD4140 |
Approved |
0.6939 |
Remote Similarity |
NPD2438 |
Suspended |
0.6939 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6929 |
Remote Similarity |
NPD1203 |
Approved |
0.6928 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD3268 |
Approved |
0.6923 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6908 |
Remote Similarity |
NPD2532 |
Approved |
0.6908 |
Remote Similarity |
NPD2534 |
Approved |
0.6908 |
Remote Similarity |
NPD2533 |
Approved |
0.6908 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD5763 |
Approved |
0.6892 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD5762 |
Approved |
0.6884 |
Remote Similarity |
NPD1611 |
Approved |
0.6875 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD7038 |
Approved |
0.6867 |
Remote Similarity |
NPD7039 |
Approved |
0.6867 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6863 |
Remote Similarity |
NPD2186 |
Approved |
0.6857
|
Remote Similarity |
NPD8651 |
Approved |